Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Oral fexinidazole for human African trypanosomiasis

Human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) is transmitted to human beings by tsetse flies in western and central Africa. Human beings are the only significant reservoir of the protozoan parasite, and disease control is focused on the detection and treatment of infected individuals, with or without vector control. Screening for cases can be passive (individuals are examined at fixed centres) or active (mobile teams travel to villages). The card agglutination test for trypanosomiasis and recently developed rapid diagnostic tests are the serological methods used for screening.

email